Find clinical trials for Melanoma in Indianapolis, IN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near Indianapolis, IN, USA:
with Opdualag to subjects with unresectable or metastatic melanoma.Subjects in dose escalation (Cohorts 1 through 3) and dose expansion (Coh...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 14 other locations
A first-in-human, Phase I, open-label, multicenter study of WTX-124 administered as monotherapy and in combination with pembrolizumab to patients wit...
Phase 1
Indianapolis, Indiana, United States and 13 other locations
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase...
Phase 1
Indianapolis, Indiana, United States and 39 other locations
This study is a Phase 1/2, first-in-human, open-label, clinical trial to assess the safety, tolerability, pharmacokinetics and preliminary efficacy o...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 5 other locations
is seeking participants who:* have advanced or metastatic non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), melanoma...
Phase 1
Indianapolis, Indiana, United States and 16 other locations
This study will test a study drug called cemiplimab to see if it can help treat early-stage cutaneous squamous cell carcinoma (CSCC), a type of skin...
Phase 3
Indianapolis, Indiana, United States and 39 other locations
This is an open-label, multi-center, single arm, Phase II study to evaluate the efficacy and safety of T-DXd for the treatment of unresectable and/or...
Phase 2
Muncie, Indiana, United States and 29 other locations
VET3-TGI is an oncolytic immunotherapy designed to treat advanced cancers. VET3-TGI has not been given to human patients yet, and the current study i...
Phase 1
Indianapolis, Indiana, United States and 6 other locations
This is a Phase 1/2A study of GV20-0251 being developed for the treatment of participants with advanced solid tumors, who are refractory to approved...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 12 other locations
or fluocinolone acetonide (FAc) intravitreal implant compared with observation on long-term visual acuity following treatment of choroidal melanoma...
Phase 3
Indianapolis, Indiana, United States and 19 other locations
Clinical trials
Research sites
Resources
Legal